DJIA 16,502.59 -11.78 -0.07%
NASDAQ 4,128.21 -33.25 -0.80%
S&P 500 1,876.31 -3.24 -0.17%
market minute promo

Seattle Genetics

NASDAQ: SGEN

39.75 -1.12 (-2.74%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SGEN $39.75 -2.74%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $40.92
Previous Close $40.87
Daily Range $38.99 - $41.03
52-Week Range $28.15 - $55.99
Market Cap $4.9B
P/E Ratio -80.14
Dividend (Yield) $0.00 (0.0%)
Volume 655,414
Average Daily Volume 1,255,892
Current FY EPS -$0.98

Sector

Healthcare

Industry

Drugs

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website: http://www.seattlegenetics.com/

News & Commentary Rss Feed

What You Need to Know About Seattle Genetics' Biggest Growth Driver

Seattle Genetics (SGEN) successful Hodgkin's lymphoma drug Adcetris has an opportunity for significant growth if ongoing trials succeed.

First Week of SGEN December 20th Options Trading

Seattle Genetics Earns Milestone Payment - Analyst Blog

Seattle Genetics Achieves Milestones Under Collaboration with Takeda for Achieving First Commercial

Seattle Genetics Achieves Milestones Under Collaboration with Takeda for Achieving First Commercial Sales of ADCETRIS

SGEN Crosses Below Key Moving Average Level

Seattle Genetics (SGEN) Showing Signs Of Being A Roof Leaker

Seattle Genetics Inc. (SGEN): Today's Featured Drugs Laggard

Seattle Genetics (SGEN) Is Today's Post-Market Loser Stock

Interesting SGEN Put And Call Options For May 17th

Jim Cramer's Top Stock Picks: SBUX JWN Z SGEN

Cramer: Seductive Words of the Fisherman Skeptic

See More SGEN News...

SGEN's Top Competitors

SGEN $39.75 (-2.74%)
Current stock: SGEN
AMGN $112.97 (-5.31%)
Current stock: AMGN
GILD $74.30 (1.98%)
Current stock: GILD
BIIB $302.52 (-1.20%)
Current stock: BIIB